China SXT manufactures and sells Traditional Chinese Medicine Pieces (TCMP), which are processed herbal medicines used to treat cardiovascular, digestive, and central nervous system conditions. The company refines medicinal plants into dosage forms including powders, capsules, and sachets. Its portfolio consists of Regular TCMP, which involves traditional processing, and Advanced TCMP, which allows for oral consumption or hot-water soaking without the traditional boiling process. Regular TCMP represents the majority of sales, while the Advanced TCMP business has declined significantly as the company’s overall operations have contracted. China SXT sells these products to traditional medicine hospitals and pharmaceutical distributors, primarily in Jiangsu province and surrounding regions. The company utilizes a distribution-light model, selling directly to hospitals and a network of third-party distributors. A key feature of the business model is that TCMP products are exempt from clinical trials and specific government drug approvals, requiring only manufacturing permits and quality compliance for sale. Most revenue comes from prescription-based sales through hospitals, where pricing for many products is subject to government-set retail ceilings. China SXT focuses its strategy on expanding the Suxuantang brand nationally, developing new oral TCMP variants, and growing its distribution network into smaller cities and rural markets.